Back to Agenda
Session 4: Communication of Safety Information - meeting stakeholder needs?
Session Chair(s)
Robyn Rennick, PhD
Director, Medical Information
GlaxoSmithKline, United Kingdom
Jill Voss, MSc
Head of Scientific Communications and Medical Information
Novartis Pharma AG, Switzerland
An interactive presentation and workshop, will explore current practice for communication of safety information and discuss potential changes to better meet stakeholder needs and embrace the evolving digital environment. The session will address current practice and understanding of risk communication. A group discussion will then explore potential options for safety communication in a world with no boundaries. This will then be challenged by debating the barriers to safety communication, through the medical information channel and address how we need to evolve our current practises in communicating safety information and the associated risk benefit.
Speaker(s)
Jan De Wit
Jan De Wit
GSK, Belgium
Director, Global Medical Information Vaccines
Communication of Safety Information: are we meeting stakeholder needs?
Sashka Hristoskova, PhD
Novartis, Switzerland
Head Medical Imformation Excellence
Communication of Safety Information: are we meeting stakeholder needs?
Marianne Wittrup Larsen, PhD, MSc
Astrazeneca, Sweden
Medical Information and Patient Safety Manager
James Milligan
James Milligan
Seqirus UK Limited, United Kingdom
Vice President Pharmacovigilance and Risk Management
Have an account?